Trials / Unknown
UnknownNCT03851562
Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
Prospective, Unicentric, Randomized, Parallel, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Correction of the deficit in the perfusion pressure of the microcirculation that supplies the nerve by intravenous infusion of Prostaglandin E1 (PGE1) (Alprostadil), expected to improve visual function in patients with ischemic optic neuropathy previous non-arteritic (NOIANA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alprostadil 20 micrograms | Intravenous infusion of PGE1 (Days 0, +1 and +2) |
| DRUG | Placebo | Intravenous infusion of physiological saline solution |
Timeline
- Start date
- 2018-06-13
- Primary completion
- 2019-06-13
- Completion
- 2019-10-31
- First posted
- 2019-02-22
- Last updated
- 2019-02-25
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03851562. Inclusion in this directory is not an endorsement.